Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by ...

We think that PORTOS could be used to help guide radiation dose-escalation and de-escalation in both the post-operative and definitive settings,” said Shuang (George) Zhao, MD.

After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels.

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

SAN FRANCISCO — A gene signature panel could help identify men with localized prostate cancer who would benefit from radiotherapy dose escalation in both the definitive and salvage settings ...

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

After surgical removal of the prostate to treat prostate ... as having recurred and prompt referral to radiation and medical oncologists to initiate salvage radiation and hormonal therapy ...

SESAUA annual meeting featured a prostate cancer session and a presentation by Dr. Arjun Pon Avudaiappan discussing survival ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

In the study cohort, 2,310 patients died during a median follow-up of 6.3 years, and prostate cancer accounted for 454 (19.7% ...